Market Place
Sourcing Support
All News #Library
Rare Diseases
Folia Health Launches BRAVE-PWS Study for Prader-Willi Syndrome
15 Apr 2026 //
GLOBENEWSWIRE
Neurocrine expands into metabolic diseases with $2.9 billion Sole
06 Apr 2026 //
REUTERS
Soleno Therapeutics Publishes VYKAT XR Study Results
05 Jan 2026 //
GLOBENEWSWIRE
Soleno Enters $100M Accelerated Share Repurchase Agreement
11 Nov 2025 //
GLOBENEWSWIRE
Soleno Therapeutics Presents New VYKAT(TM) XR Data
25 Jun 2025 //
GLOBENEWSWIRE
Soleno Therapeutics Submits EMA Application for Diazoxide Choline
22 May 2025 //
GLOBENEWSWIRE
Soleno Therapeutic Presents Vykat(TM) XR in Prader-Willi Syndrome
15 May 2025 //
GLOBENEWSWIRE
Soleno Therapeutics Presents VYKAT(TM) XR at ISPOR 2025
13 May 2025 //
GLOBENEWSWIRE
Soleno Therapeutics Announces Vykat(TM) XR Launch
14 Apr 2025 //
GLOBENEWSWIRE
PANTHERx Rare Selected for Vykat XR Distribution
28 Mar 2025 //
PR NEWSWIRE
US FDA approves first treatment for Prader-Willi syndrome
27 Mar 2025 //
REUTERS
Soleno Jumps As Analysts Hail Rare Disease Drug Approval
27 Mar 2025 //
REUTERS
Soleno Therapeutics Announces FDA Review Extension for DCCR Tablets
26 Nov 2024 //
GLOBENEWSWIRE
Soleno Therapeutics To Present At Cantor Healthcare Conference
16 Sep 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.